| Literature DB >> 35434438 |
Minghui Liu1,2, Lukas Bauman1,2, Christiane Lourenco Nogueira1, Marc G Aucoin1, William A Anderson1, Boxin Zhao1,2.
Abstract
Antimicrobial polymer composites have long been utilized in the healthcare field as part of the first line of defense. These composites are desirable in that they pose a minimal risk of developing contagions with antibiotic resistance. For this reason, the field of antimicrobial composites has seen steady growth over recent years and is becoming increasingly important during the current COVID-19 pandemic. In this article, we first review the need of the antimicrobial polymers in high tough surfaces, the antimicrobial mechanism, and then the recent advances in the development of antimicrobial polymer composite including the utilization of intrinsic antimicrobial polymers, the addition of antimicrobial additives, and new exploration of surface patterning. While there are many established and developing methods of imbuing a material with antimicrobial activity, there currently is no standard quantification method for these properties leading to difficulty comparing the efficacy of these materials within the literature. A discussion of the common antimicrobial characterization methods is provided along with highlights on the need of a standardized quantification of antiviral and antibacterial properties in testing to allow ease of comparison between generated libraries and to facilitate proper screening. We also discuss and comment on the current trends of the development of antimicrobial polymer composites with long-lasting and specific antimicrobial activities, nontoxic properties, and environmental friendliness against a broad-spectrum of microbes.Entities:
Keywords: Antibacterial; Antimicrobial polymeric composite; Antiviral; Health-care materials; High-touch surfaces
Year: 2022 PMID: 35434438 PMCID: PMC8995198 DOI: 10.1016/j.cobme.2022.100395
Source DB: PubMed Journal: Curr Opin Biomed Eng ISSN: 2468-4511
Figure 1Schematic illustration of three typical types of antimicrobial polymers: a) polymeric biocides consisting of repeating biocidal units; b) biocidal polymers a macromolecule containing at least one biocidal group; c) biocide releasing polymers consisting of a matrix filled with a biocidal agent that releases over time.
An overview of selected publications measuring antimicrobial efficacy on polymer-based surfaces.
| Material | Microbes | Conditions | Measures | Ref. |
|---|---|---|---|---|
| Functionalized poly-lactic acid films | Overnight cultures at 0.07 OD600, 24 h droplet on polymer contact | Plate counts | [ | |
| Amphiphilic ternary polymers | Broth dilution method of polymer samples | Minimum inhibitory concentration | [ | |
| Functionalized polyurethane (PU) | Broth incubation (5 × 107 CFU/mL) at 37°C for 16 h | Plate count | [ | |
| 107 CFU of | Live/dead staining with confocal microscopy | [ | ||
| SARS-CoV-2, enveloped TGEV, | 100 μL of virus suspension were added on the test sample, which were incubated for various times before the virus was recovered by vortexing the sample with medium. | 50% tissue culture infective dose (TCID50) assay | [ | |
| Functionalized PU films | 106 cfu/mL submerged polymer incubation for 48 h at 37°C. | Plate counts | [ | |
| Functionalized silicone (Polydimethyl-siloxane also known as PDMS) | 108 cfu/mL droplets on polymer for 3 h at 37°C with humidity. | Plate counts | [ | |
| Cuprous oxide (Cu2O) particles bound with PU | SARS-CoV-2 | 5 μL of virus suspension were added on the test solid, which were incubated until the droplets were desiccated. The surface was soaked in 300 μL of medium. | 50% tissue culture infective dose (TCID50) assay | [ |
| Silver nanoparticle (AgNP)-coated polyurethane | HIV-1 and HSV-1/2 | HIV-1: 200 μL of HIV suspension were incubated with the AgNPs-coated polyurethane. Viruses were collected and used to infect T cells. | Assayed by the observation of levels of viruses-induced syncytium formation and HIV-1-infected (GFP+) cells microscopy | [ |
| AgNP-chitosan | Influenza A virus | Viral suspension was added to 250 μL AgNP-chitosan composite suspension. After 1 h, samples were centrifuged. | The supernatant was used to infect MDCK cells and the virus was titrated by TCID50. | [ |
| Polyethylene coated with linear N,N-dodecyl,methyl-PEI | Non-enveloped poliovirus and rotavirus. | 10 μL of a virus suspension was added on a coated slide and the droplet was sandwiched with a bare slide. After 30 min incubation at room temperature, the sandwiched slides were washed with cell culture medium. | Plaque assay | [ |
List of intrinsic antimicrobial polymers, their structure and mechanism of action.
| Intrinsic antimicrobial polymers | Monomer structure | Mechanisms of antimicrobial action | Remarks |
|---|---|---|---|
| Chitosan | Cell wall destruction by protonated amine groups when pH < pKa, chelation and hydrophobic interactions pH < pKa, | Water-soluble, biocompatible and biodegradable. | |
| ε-poly- | Cell wall destruction by a protonated amine groups | Biodegradable, nontoxic, thermostable and water-soluble. | |
| QACs | Cell wall destruction by a cationic quaternary amine groups | High chemical stability. | |
| Polyethyleneimine | Cell wall destruction by a protonated amine groups | Non-volatile, having long-term effectiveness and lower hemolytic activity. | |
| Polyguanidines | Interrupting Ca2+ salt bridges present in the cell membrane leading to phase separation and disruption of the cellular membrane. | Water-soluble, nontoxic. | |
| N-halamines | Through the oxidative halogen present in the structure that attacks the amino or thio groups of cell receptors. | Having long-term stability under both dry and aqueous condition. |